Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Details for Australian Patent Application No. 2010204554 (hide)

Owner Abbott Laboratories

Inventors Hexamer, Laura; Ding, Hong; Elmore, Steven W.; Kunzer, Aaron R.; Song, Xiaohong; Souers, Andrew J.; Sullivan, Gerard M.; Tao, Zhi-fu; Wendt, Michael D.

Agent Spruson & Ferguson

Pub. Number AU-A-2010204554

PCT Pub. Number WO2010/083441

Priority 61/145,627 19.01.09 US

Filing date 15 January 2010

Wipo publication date 22 July 2010

International Classifications

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/635 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 235/04 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 265/02 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 285/14 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 311/14 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/083441 Priority application(s): WO2010/083441

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204555-Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

2010204552-New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein